cs.LGNov 6, 2026

Match the Geometry Before the Surrogate: Extreme Low-Budget Optimization in High Dimensions

Authors: Michal Průšek, Adam Novozámský, Filip Šroubek

Organizations: Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague · Institute of Information Theory and Automation, Czech Academy of Sciences, Prague

Abstract

Low-budget molecular optimization is often framed as Bayesian optimization in a learned latent space, but standard benchmarks typically allow hundreds or thousands of evaluations, whereas a realistic wet-lab round may allow only a few dozen. We revisit this regime using a SELFIES molecular variational autoencoder (VAE) with a Gaussian prior and GuacaMol objectives at N = 30 evaluations. The main finding is not a new surrogate model, but an interaction in candidate generation. The encoder means of a reference set of molecules concentrate near a narrow spherical shell, while many high-dimensional optimizers propose candidates from boxes or box-shaped trust regions. We study a simple constraint, the on-sphere scaffold, that restricts candidate generation to this shell. We then introduce two minimal optimizers to probe what remains useful once the support is fixed. GeoWalk performs geodesic local search on the shell without a surrogate. After 30 evaluations, it shows no detected difference from a Gaussian-process (GP) surrogate on the shell, which is ahead earlier in the budget. GeoCMA adds covariance learning in a random subspace. It does not improve on GeoWalk in the molecular benchmark. On LassoBench it has a lower mean loss than GeoWalk, but full-dimensional CMA-ES remains stronger on most tasks. A factorial experiment with a single GP crosses the candidate support (shell or box) with the acquisition maximizer (a finite candidate set or a continuous optimizer). In this benchmark, shell candidates outperformed box candidates when acquisition was maximized over a candidate set, but not with continuous maximization by L-BFGS-B. These results come from a controlled study of one Gaussian-prior VAE benchmark and do not recommend VAEs for molecular optimization. The practical lesson is to control the candidate support and the acquisition maximizer before attributing a gain to the surrogate.

Figures & tables

Appendix figures & tables3 assets

Supplementary material from the paper’s appendix.

Appendix

Explore similar work

Sep 16, 2026

Search at the Cost of Sampling: Nearly-Instant Latent Space Bayesian Optimization

Generative models are increasingly central to many de novo discovery pipelines, in which designs are generated at scale and filtered through virtual screens to determine a set of candidates to experimentally validate. While Bayesian optimization (BO) is a natural fit for this setting, as it uses past evaluations to guide future proposals, the computational overhead required for its sequential decision-making becomes a bottleneck when virtual screens are relatively cheap. We make BO practical in this regime by exploiting the unique combination of a linear model constrained to a spherical domain where high-dimensional latents concentrate. We build off recent work justifying the use of linear surrogates, while deriving nearly closed-form solutions to the surrogate modelling and acquisition problems that exploit spherical symmetry. The result is at least a 100x speedup over state-of-the art baselines, with matching or improved performance across molecular and image generation benchmarks. Altogether, our method makes BO a practical drop-in for de novo pipelines where it was previously too slow to consider.
Jul 14, 2026

Sample Efficient Generative Optimization for Molecular Design

Molecular optimization in drug discovery, materials design, and catalysis requires searching vast chemical spaces under tight evaluation budgets, since high-fidelity oracles and experimental measurements are costly. The practical impact of an optimization method therefore hinges on its sample efficiency: how few evaluations it needs to find strong candidates. We introduce Sample Efficient Generative Optimization (SEGO), a framework for Bayesian optimization on adaptively generated molecules. In SEGO, a probabilistic surrogate model forms a hypothesis about where hits lie in chemical space, a generative model is steered to propose candidates in that region, the most promising candidate is selected via an acquisition function, and the resulting oracle call is used both to sharpen the surrogate and to anchor the generator in real reward. SEGO attains state-of-the-art performance on the practical molecular optimization (PMO) benchmark using only one tenth of the oracle calls consumed by other methods, and on a multiparameter docking task it reaches ten hits in roughly half the oracle calls of existing approaches. These gains move molecular optimization closer to campaigns driven by direct experimental feedback.
Jun 8, 2026

In-Context Learning for Latent Space Bayesian Optimization

Bayesian optimization (BO) is a central tool for sample-efficient design, and latent-space Bayesian optimization (LSBO) extends it to structured objects such as molecules and proteins. In parallel, tabular foundation models such as TabPFN and TabICL now achieve state-of-the-art regression performance and are increasingly used as BO surrogates. Because their Bayesian behavior is induced by large synthetic pretraining collections, the composition of this pretraining distribution is crucial. LSBO creates a distinctive mismatch: the induced map from latent code to objective value differs markedly from the regression tasks used to train current in-context models. We address this mismatch by complementing the pretraining stage of tabular foundation model surrogates with synthetic optimization tasks defined on the latent space of a molecular VAE. The continued-pretraining objective features a regularizer that anchors the model to the original checkpoint, preserving its broad regression prior while avoiding overspecialization to the adaptation tasks. On held-out molecular optimization benchmarks, the resulting model achieves strong performance, supporting the relevance of LSBO-specific adaptation for in-context surrogates.